Evidence map›Paper›PMID 28750007›Full record

ArticlePLoS neglected tropical diseases2017

Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad).

Mahamat Hissene Mahamat, Mallaye Peka, Jean-Baptiste Rayaisse, Kat S Rock, Mahamat Abdelrahim Toko, Justin Darnas, Guihini Mollo Brahim, Ali Bachar Alkatib, Wilfrid Yoni, Inaki Tirados and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Modeling framework to demonstrate elimination of a vector population: Tsetse elimination in Chad.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Mahamat Hissene MahamatInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Mallaye PekaProgramme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Moundou, Chad.
Jean-Baptiste RayaisseCentre International de Recherche Développement sur l'Elevage en zone Subhumide (CIRDES), Bobo-Dioulasso, Burkina Faso.
Kat S RockUniversity of Warwick, Coventry, United Kingdom.
Mahamat Abdelrahim TokoInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Justin DarnasProgramme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Moundou, Chad.
Guihini Mollo BrahimInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Ali Bachar AlkatibInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Wilfrid YoniCentre International de Recherche Développement sur l'Elevage en zone Subhumide (CIRDES), Bobo-Dioulasso, Burkina Faso.
Inaki TiradosLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Fabrice CourtinInstitut de Recherche pour le Développement, UMR 177 Intertryp IRD-CIRAD, Montpellier, France.
Samuel P C BrandUniversity of Warwick, Coventry, United Kingdom.
Cyrus NersyInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Idriss Oumar AlfaroukhInstitut de Recherche en Elevage pour le Développement (IRED), Ndjaména, Chad.
Steve J TorrUniversity of Warwick, Coventry, United Kingdom.
Mike J LehaneLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Philippe SolanoInstitut de Recherche pour le Développement, UMR 177 Intertryp IRD-CIRAD, Montpellier, France.
Association Sahélienne de Recherche Appliquée pour le Développement Durable · TDUniversity of Warwick · GBCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRCentre international de recherche-développement sur l'elevage en zone subhumide · BFLiverpool School of Tropical Medicine · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundGambian sleeping sickness or HAT (human African trypanosomiasis) is a neglected tropical disease caused by Trypanosoma brucei gambiense transmitted by riverine species of tsetse. A global programme aims to eliminate the disease as a public health problem by 2020 and stop transmission by 2030. In the South of Chad, the Mandoul area is a persistent focus of Gambian sleeping sickness where around 100 HAT cases were still diagnosed and treated annually until 2013. Pre-2014, control of HAT relied solely on case detection and treatment, which lead to a gradual decrease in the number of cases of HAT due to annual screening of the population.

methodsBecause of the persistence of transmission and detection of new cases, we assessed whether the addition of vector control to case detection and treatment could further reduce transmission and consequently, reduce annual incidence of HAT in Mandoul. In particular, we investigated the impact of deploying 'tiny targets' which attract and kill tsetse. Before tsetse control commenced, a census of the human population was conducted and their settlements mapped. A pre-intervention survey of tsetse distribution and abundance was implemented in November 2013 and 2600 targets were deployed in the riverine habitats of tsetse in early 2014, 2015 and 2016. Impact on tsetse and on the incidence of sleeping sickness was assessed through nine tsetse monitoring surveys and four medical surveys of the human population in 2014 and 2015. Mathematical modelling was used to assess the relative impact of tsetse control on incidence compared to active and passive screening.

findingsThe census indicated that a population of 38674 inhabitants lived in the vicinity of the Mandoul focus. Within this focus in November 2013, the vector is Glossina fuscipes fuscipes and the mean catch of tsetse from traps was 0.7 flies/trap/day (range, 0-26). The catch of tsetse from 44 sentinel biconical traps declined after target deployment with only five tsetse being caught in nine surveys giving a mean catch of 0.005 tsetse/trap/day. Modelling indicates that 70.4% (95% CI: 51-95%) of the reduction in reported cases between 2013 and 2015 can be attributed to vector control with the rest due to medical intervention. Similarly tiny targets are estimated to have reduced new infections dramatically with 62.8% (95% CI: 59-66%) of the reduction due to tsetse control, and 8.5% (95% 8-9%) to enhanced passive detection. Model predictions anticipate that elimination as a public health problem could be achieved by 2018 in this focus if vector control and screening continue at the present level and, furthermore, there may have been virtually no transmission since 2015.

conclusionThis work shows that tiny targets reduced the numbers of tsetse in this focus in Chad, which may have interrupted transmission and the combination of tsetse control to medical detection and treatment has played a major role in reducing in HAT incidence in 2014 and 2015.

Indexed as

AnimalsCensusesChadFemaleHumansIncidenceInsect ControlInsect VectorsMaleMass ScreeningModels, TheoreticalNitrilesPyrethrinsTrypanosoma brucei gambienseTrypanosomiasis, AfricanTsetse FliesdecamethrinNitrilesPyrethrins

Identifiers

PMID28750007
PMCPMC5549763
OpenAlexW2742116434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.